Aggressive hepatocellular carcinoma complicating pregnancy after autologous bone marrow transplantation for non-Hodgkin's lymphoma

被引:9
作者
Au, WY
Lie, AKW
Liang, R
Liu, CL
Shek, TW
Lau, GK
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China
[3] Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
关键词
autologous bone marrow transplanation; hepatitis B virus; hepatocellular carcinoma; pregnancy;
D O I
10.1038/sj.bmt.1703339
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
In the Asia-Pacific region, autologous and allogeneic bone marrow transplantation (BMT) in patients infected with the hepatitis B virus (HBV) may be complicated by fatal hepatic failure due to viral reactivation. Survivors may suffer from accelerated hepatitis and cirrhosis. We report the first case of hepatocellular carcinoma (HCC) after autologous BMT for mediastinal B cell lymphoma. The tumor developed rampantly during a planned pregnancy 5 years after BMT. Less than 40 cases of HCC complicating pregnancy have been reported, and outcome is invariably poor. Immunosuppression and HBV reactivation after autologous BMT, as well as immune tolerance and hormonal changes associated with pregnancy may contribute to the rapid tumor growth. Biochemical and radiological surveillance for HCC should be strengthened in HBV carriers after BMT, especially in patients with the histology of chronic liver disease, or biochemical/virological evidence of increased HBV activity.
引用
收藏
页码:177 / 179
页数:3
相关论文
共 20 条
  • [1] Pregnancy and secondary cancer after allogeneic bone marrow transplantation
    Arcese, W
    Iori, AP
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 (07) : 752 - 752
  • [2] Hepatocellular carcinoma as a rare cause of an excessive increase in alpha-fetoprotein during pregnancy
    Entezami, M
    Becker, R
    Ebert, A
    Pritze, W
    Weitzel, H
    [J]. GYNECOLOGIC ONCOLOGY, 1996, 62 (03) : 405 - 407
  • [3] Comparison of the second-generation digene hybrid capture assay with the branched-DNA assay for measurement of hepatitis B virus DNA in serum
    Ho, SKN
    Chan, TM
    Cheng, IKP
    Lai, KN
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (08) : 2461 - 2465
  • [4] Hepatic events after bone marrow transplantation in patients with hepatitis B infection: A case controlled study
    Lau, GKK
    Liang, R
    Chiu, EKW
    Lee, CK
    Lam, SK
    [J]. BONE MARROW TRANSPLANTATION, 1997, 19 (08) : 795 - 799
  • [5] Clearance of hepatitis B surface antigen after bone marrow transplantation: Role of adoptive immunity transfer
    Lau, GKK
    Lok, ASF
    Liang, RHS
    Lai, CL
    Chiu, EKW
    Lau, YL
    Lam, SK
    [J]. HEPATOLOGY, 1997, 25 (06) : 1497 - 1501
  • [6] Lau GKK, 2000, BLOOD, V96, P452
  • [7] LAU WY, 1995, CANCER-AM CANCER SOC, V75, P2669, DOI 10.1002/1097-0142(19950601)75:11<2669::AID-CNCR2820751105>3.0.CO
  • [8] 2-B
  • [9] Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: A review of the problem
    Liang, R
    Lau, GKK
    Kwong, YL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 394 - 398
  • [10] The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: A prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group
    Locasciulli, A
    Testa, M
    Valsecchi, MG
    Bacigalupo, A
    Solinas, S
    Tomas, JF
    Ljungman, P
    Alberti, A
    [J]. TRANSPLANTATION, 1999, 68 (10) : 1486 - 1491